Viewing StudyNCT04861181

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 4:05 PM
Last Modification Date: 2024-10-26 @ 2:03 PM
Study NCT ID: NCT04861181
Status: RECRUITING
Last Update Posted: 2022-04-20
First Post: 2021-04-20
Brief Title: NIRAPK Study of the Relationships Between Clinical Biological and Pharmacokinetic Metrics and Toxicities When Niraparib is Used as Maintenance Treatment for Ovarian Cancer Patients
Sponsor: Hospices Civils de Lyon
Organization: Hospices Civils de Lyon
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Adult Patients With Platinum-sensitive Relapsed High Grade Serous Epithelial Ovarian Cancer
Keywords:
Name View
Predictive factors View
Niraparid View
Pharmacokinetic View
Hematologic toxicity View
Nephrotoxicity View
Thrombocytopenia View
Maintenance treatment View
Ovarian cancer View